503 First results of diflomotecan, a new topoisomerase 1 inhibitor, as oral soft-gel capsules in a phase I dose escalation study in patients with advanced malignant solid tumours
T. Lesimple, P. Fumoleau, A. Lortholary, J. Egreteau, M. Campone, P. Soulie, B. Le MosquetVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80511-1
File:
PDF, 284 KB
english, 2004